XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | |
---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | |||||
Cash flow from continuing operating activities | -553.67K | -59K | -42.82K | -414.2K | -37.64K |
Net income from continuing operations | --1.92M | --751.7K | --883.77K | --310.94K | ---30.7K |
Other non cash items | ---2.48M | ---850.6K | ---965.49K | ---- | ---- |
Change In working capital | --14.9K | --39.9K | --38.9K | ---56.97K | ---6.94K |
-Change in prepaid assets | ---49.23K | --19.43K | --19.64K | ---86.76K | ---1.54K |
-Change in payables and accrued expense | --64.13K | --20.47K | --19.26K | --29.79K | ---5.39K |
Cash from discontinued investing activities | |||||
Operating cash flow | ---553.67K | ---59K | ---42.82K | ---414.2K | ---37.64K |
Investing cash flow | |||||
Cash flow from continuing investing activities | -69.35M | 0 | 0 | ||
Net investment purchase and sale | ---69.35M | --0 | --0 | ---- | ---- |
Cash from discontinued investing activities | |||||
Investing cash flow | ---69.35M | --0 | --0 | ---- | ---- |
Financing cash flow | |||||
Cash flow from continuing financing activities | 70.04M | 0 | 0 | 70.07M | -28.06K |
Net issuance payments of debt | ---250K | --0 | --0 | ---- | ---- |
Net common stock issuance | --72.05M | --0 | --0 | ---- | ---- |
Net other financing activities | ---1.76M | --0 | --0 | ---1.73M | ---28.06K |
Cash from discontinued financing activities | |||||
Financing cash flow | --70.04M | --0 | --0 | --70.07M | ---28.06K |
Net cash flow | |||||
Beginning cash position | --125.1K | --323.85K | --366.67K | --59.4K | --125.1K |
Current changes in cash | --139.74K | ---59K | ---42.82K | --307.27K | ---65.7K |
End cash Position | --264.84K | --264.84K | --323.85K | --366.67K | --59.4K |
Free cash flow | ---553.67K | ---59K | ---42.82K | ---414.2K | ---37.64K |
Currency Unit | USD | USD | USD | USD | USD |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |